128 related articles for article (PubMed ID: 19293355)
1. Effects of beraprost sodium, an oral prostaglandin i2 analog, on hemostatic factors and inflammation in chronic peritoneal dialysis patients.
Kim KM; Kim HW; Lee JH; Chang JW; Park JS; Kim SB
Perit Dial Int; 2009; 29(2):178-81. PubMed ID: 19293355
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of beraprost sodium in maintaining vascular access patency in patients on hemodialysis.
Kim M; Kim JU; Kim SM; Kim H
Int Urol Nephrol; 2017 Jul; 49(7):1287-1295. PubMed ID: 28409403
[TBL] [Abstract][Full Text] [Related]
3. [Clinical efficacy and safety of sequential treatment with alprostadil and beraprost sodium for chronic renal failure induced by chronic glomerulonephritis].
Chen Y; Wan JX; Jiang DW; Fu BB; Cui J; Li GF
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1521-4. PubMed ID: 24144760
[TBL] [Abstract][Full Text] [Related]
4. Effects of sulodexide on hemostatic factors, lipid profile, and inflammation in chronic peritoneal dialysis patients.
Kim SB; Kim SH; Lee MS; Chang JW; Lee SK; Park JS
Perit Dial Int; 2007; 27(4):456-60. PubMed ID: 17602156
[TBL] [Abstract][Full Text] [Related]
5. Effects of beraprost sodium, a new prostaglandin I2 analog, on parameters of hemostasis, fibrinolysis, and myocardial ischemia in patients with exertional angina.
Sakata K; Hoshino T; Yoshida H; Kaburagi T; Takada A
Cardiovasc Drugs Ther; 1995 Aug; 9(4):601-7. PubMed ID: 8547211
[TBL] [Abstract][Full Text] [Related]
6. Effects of Ginkgo biloba on haemostatic factors and inflammation in chronic peritoneal dialysis patients.
Kim SH; Lee EK; Chang JW; Min WK; Chi HS; Kim SB
Phytother Res; 2005 Jun; 19(6):546-8. PubMed ID: 16114087
[TBL] [Abstract][Full Text] [Related]
7. Effects of fixed low-dose warfarin on hemostatic factors in continuous ambulatory peritoneal dialysis patients.
Kim SB; Lee SK; Park JS; Chi HS; Hong CD; Yang WS
Am J Kidney Dis; 2001 Feb; 37(2):343-7. PubMed ID: 11157376
[TBL] [Abstract][Full Text] [Related]
8. Beraprost: a review of its pharmacology and therapeutic efficacy in the treatment of peripheral arterial disease and pulmonary arterial hypertension.
Melian EB; Goa KL
Drugs; 2002; 62(1):107-33. PubMed ID: 11790158
[TBL] [Abstract][Full Text] [Related]
9. Comparison of antiplatelet potency of sarpogrelate, aspirin, and beraprost in healthy volunteers according to in-vitro closure time.
Kim KM; Kim H; Chi HS; Park JS; Kim SB
Blood Coagul Fibrinolysis; 2010 Apr; 21(3):262-5. PubMed ID: 20124989
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacological and clinical properties of beraprost sodium, orally active prostacyclin analogue].
Nishio S; Kurumatani H
Nihon Yakurigaku Zasshi; 2001 Feb; 117(2):123-30. PubMed ID: 11233303
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of oral beraprost sodium, a prostaglandin I2 analogue, for treating intermittent claudication in patients with arteriosclerosis obliterans.
Matsumoto T; Iwasa K; Kyuragi R; Honma K; Guntani A; Ohmine T; Itoh H; Onohara T; Maehara Y
Int Angiol; 2010 Apr; 29(2 Suppl):49-54. PubMed ID: 20357749
[TBL] [Abstract][Full Text] [Related]
12. A dose-effect study of beraprost sodium in intermittent claudication.
Lievre M; Azoulay S; Lion L; Morand S; Girre JP; Boissel JP
J Cardiovasc Pharmacol; 1996 Jun; 27(6):788-93. PubMed ID: 8761844
[TBL] [Abstract][Full Text] [Related]
13. Lack of effects of low-dose aspirin on high-sensitivity C-reactive protein, hemostatic factors, and troponin T in CAPD patients.
Kim SB; Lee SK; Min WK; Chi HS; Park JS
Perit Dial Int; 2002; 22(6):721-3. PubMed ID: 12556076
[No Abstract] [Full Text] [Related]
14. Beraprost sodium: a stable prostaglandin I2 analogue.
Battal MN; Hata Y
Br J Plast Surg; 1997 Jan; 50(1):69-70. PubMed ID: 9038519
[No Abstract] [Full Text] [Related]
15. Platelet-aggregation inhibition and hemodynamic effects of beraprost sodium, a new oral prostacyclin derivative: a study in healthy male subjects.
Nony P; Ffrench P; Girard P; Delair S; Azoulay S; Girre JP; Dechavanne M; Boissel JP
Can J Physiol Pharmacol; 1996 Aug; 74(8):887-93. PubMed ID: 8960377
[TBL] [Abstract][Full Text] [Related]
16. Effects of Beraprost sodium on subjective symptoms in diabetic patients with peripheral arterial disease.
Yoon HS; Choi WJ; Sung IH; Lee HS; Chung HJ; Lee JW
Clin Orthop Surg; 2013 Jun; 5(2):145-51. PubMed ID: 23730480
[TBL] [Abstract][Full Text] [Related]
17. Effect of beraprost sodium (Procylin), a stable prostaglandin I2 analogue, on a dorsal skin flap model in rats.
Alexandrou K; Hata Y; Matsuka K; Matsuda H
Scand J Plast Reconstr Surg Hand Surg; 1996 Mar; 30(1):17-22. PubMed ID: 8711437
[TBL] [Abstract][Full Text] [Related]
18. Treatment of intermittent claudication with beraprost sodium, an orally active prostaglandin I2 analogue: a double-blinded, randomized, controlled trial.
Mohler ER; Hiatt WR; Olin JW; Wade M; Jeffs R; Hirsch AT
J Am Coll Cardiol; 2003 May; 41(10):1679-86. PubMed ID: 12767646
[TBL] [Abstract][Full Text] [Related]
19. Reduction of progressive burn injury by a stable prostaglandin I2 analogue, beraprost sodium (Procylin): an experimental study in rats.
Battal MN; Hata Y; Matsuka K; Ito O; Matsuda H; Yoshida Y; Kawazoe T
Burns; 1996 Nov; 22(7):531-8. PubMed ID: 8909753
[TBL] [Abstract][Full Text] [Related]
20. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
